Study to Evaluate Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors

- Neutropenia
- Completed

Study Title: A Study to Evaluate 5 ־¼g/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

Teva Identifier: XM02-ONC-201 | 2014-001772-55

ClinicalTrials.gov Identifier: NCT02190721

Study Status: Completed

Trial Condition(s): Neutropenia

Interventions: Drug: tbo-filgrastim

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 1 Month to 16 Years

Trial Duration: May 12, 2015 - April 4, 2017

Phase: Phase 2

Study Type

Interventional